<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>NNN Buzz - Latest pharmaceutical stocks News &amp; Blogs</title>
    <link>https://www.nnnbuzz.com/topic/pharmaceutical%20stocks</link>
    <description>Stay updated with the latest pharmaceutical stocks articles, blogs, and stories from NNN Buzz</description>
    <language>en-US</language>
    <lastBuildDate>Wed, 03 Jun 2026 05:18:45 GMT</lastBuildDate>
    <managingEditor>admin@nnnbuzz.com (NNN Buzz)</managingEditor>
    <webMaster>admin@nnnbuzz.com (NNN Buzz)</webMaster>
    <ttl>15</ttl>
    <generator>Keynate Topic RSS Generator</generator>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.nnnbuzz.com/topic/pharmaceutical%20stocks/rss" rel="self" type="application/rss+xml" />
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.nnnbuzz.com/topic/pharmaceutical%20stocks" rel="alternate" type="text/html" />
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" rel="hub" href="https://pubsubhubbub.appspot.com/" />
    <image>
      <title>NNN Buzz - Latest pharmaceutical stocks News &amp; Blogs</title>
      <url>https://www.nnnbuzz.com/apple-touch-icon.png</url>
      <link>https://www.nnnbuzz.com/topic/pharmaceutical%20stocks</link>
      <width>96</width>
      <height>96</height>
    </image>
    <item>
      <title>Zydus Lifesciences shares fall over 2% after USFDA issues warning letter for Baddi facility</title>
      <link>https://www.nnnbuzz.com/news/zydus-lifesciences-shares-fall-over-2-after-usfda-issues-warning-letter-for-baddi-facility</link>
      <description>&lt;a href="https://www.nnnbuzz.com/news/zydus-lifesciences-shares-fall-over-2-after-usfda-issues-warning-letter-for-baddi-facility"&gt;&lt;img alt="Zydus Lifesciences shares fall over 2% after USFDA issues warning letter for Baddi facility" src="https://www.nnnbuzz.com/view/aman/untitled-design-88.jpg"&gt;&lt;/a&gt;&lt;p&gt;Zydus Lifesciences shares declined over 2% after the company received a USFDA Warning Letter related to its Baddi manufacturing facility. The company said operations and product supplies remain unaffected.&lt;/p&gt;</description>
      <category>Zydus Lifesciences share price</category>
      <category>Zydus Lifesciences USFDA warning letter</category>
      <category>Zydus Baddi facility</category>
      <category>Zydus stock news</category>
      <category>pharmaceutical stocks</category>
      <category>USFDA observations</category>
      <category>Zydus Lifesciences shares</category>
      <category>stock market news</category>
      <pubDate>Wed, 03 Jun 2026 05:18:45 GMT</pubDate>
      <guid>https://www.nnnbuzz.com/news/zydus-lifesciences-shares-fall-over-2-after-usfda-issues-warning-letter-for-baddi-facility</guid>
    </item>
    <item>
      <title>Jubilant Pharmova shares in focus on Monday after USFDA issues warning letter to Canadian subsidiary</title>
      <link>https://www.nnnbuzz.com/news/jubilant-pharmova-shares-in-focus-on-monday-after-usfda-issues-warning-letter-to-canadian-subsidiary</link>
      <description>&lt;a href="https://www.nnnbuzz.com/news/jubilant-pharmova-shares-in-focus-on-monday-after-usfda-issues-warning-letter-to-canadian-subsidiary"&gt;&lt;img alt="Jubilant Pharmova shares in focus on Monday after USFDA issues warning letter to Canadian subsidiary" src="https://www.nnnbuzz.com/view/aman/untitled-design-26.jpg"&gt;&lt;/a&gt;&lt;p&gt;Jubilant Pharmova shares will remain in focus after its subsidiary, Jubilant HollisterStier General Partnership, received a USFDA warning letter following an inspection of its Kirkland, Canada facility.&lt;/p&gt;</description>
      <category>Jubilant Pharmova share price</category>
      <category>Jubilant Pharmova news</category>
      <category>USFDA warning letter</category>
      <category>Jubilant HollisterStier</category>
      <category>Kirkland Canada facility</category>
      <category>pharmaceutical stocks</category>
      <category>CDMO business</category>
      <category>Jubilant Pharma</category>
      <pubDate>Sat, 30 May 2026 04:31:04 GMT</pubDate>
      <guid>https://www.nnnbuzz.com/news/jubilant-pharmova-shares-in-focus-on-monday-after-usfda-issues-warning-letter-to-canadian-subsidiary</guid>
    </item>
    <item>
      <title>Lupin shares in focus on Monday after USFDA approval for Generic Sutab tablets</title>
      <link>https://www.nnnbuzz.com/news/lupin-shares-in-focus-on-monday-after-usfda-approval-for-generic-sutab-tablets</link>
      <description>&lt;a href="https://www.nnnbuzz.com/news/lupin-shares-in-focus-on-monday-after-usfda-approval-for-generic-sutab-tablets"&gt;&lt;img alt="Lupin shares in focus on Monday after USFDA approval for Generic Sutab tablets" src="https://www.nnnbuzz.com/view/aman/untitled-design-25.jpg"&gt;&lt;/a&gt;&lt;p&gt;Lupin shares may remain in focus on Monday after the company received USFDA approval for its generic version of Sutab tablets. The drug has annual U.S. sales of $132.8 million.&lt;/p&gt;</description>
      <category>Lupin share price</category>
      <category>Lupin USFDA approval</category>
      <category>Lupin ANDA approval</category>
      <category>Sutab generic tablets</category>
      <category>Lupin news</category>
      <category>pharmaceutical stocks</category>
      <category>Lupin Nagpur facility</category>
      <category>USFDA approval 2026</category>
      <category>Lupin stock news</category>
      <category>healthcare stocks India</category>
      <pubDate>Sat, 30 May 2026 04:08:50 GMT</pubDate>
      <guid>https://www.nnnbuzz.com/news/lupin-shares-in-focus-on-monday-after-usfda-approval-for-generic-sutab-tablets</guid>
    </item>
    <item>
      <title>Torrent Pharma shares rally over 4% to hit new 52-week high despite Q4 profit decline</title>
      <link>https://www.nnnbuzz.com/news/torrent-pharma-shares-rally-over-4-to-hit-new-52-week-high-despite-q-4-profit-decline</link>
      <description>&lt;a href="https://www.nnnbuzz.com/news/torrent-pharma-shares-rally-over-4-to-hit-new-52-week-high-despite-q-4-profit-decline"&gt;&lt;img alt="Torrent Pharma shares rally over 4% to hit new 52-week high despite Q4 profit decline" src="https://www.nnnbuzz.com/view/aman/untitled-design-59.jpg"&gt;&lt;/a&gt;&lt;p&gt;Torrent Pharma shares surged over 4% to hit a new 52-week high despite a decline in Q4 FY26 profit.&lt;/p&gt;</description>
      <category>Torrent Pharma share price</category>
      <category>Torrent Pharma Q4 results</category>
      <category>Torrent Pharmaceuticals FY26</category>
      <category>Torrent Pharma 52week high</category>
      <category>Torrent Pharma EBITDA</category>
      <category>Torrent Pharma revenue growth</category>
      <category>pharmaceutical stocks</category>
      <category>Indian pharma sector</category>
      <pubDate>Mon, 25 May 2026 05:15:00 GMT</pubDate>
      <guid>https://www.nnnbuzz.com/news/torrent-pharma-shares-rally-over-4-to-hit-new-52-week-high-despite-q-4-profit-decline</guid>
    </item>
  </channel>
</rss>
